-
1. Oculocutaneous albinism （OCA） in Japanese patients: five novel mutations. J Dermatol Sci 2014; 74: 173-174.
Okamura K, Yoshizawa J, Abe Y, Hanaoka K, Higashi N, Togawa Y, Nakagawa S, Kambe N, Funasaka Y, Ohko K, Hozumi Y, Suzuki T.
-
2. Mutation analyses of patients with dyschromatosis symmetrica hereditaria: Ten novel mutations of the ADAR1 gene. J Dermatol Sci 2015; 79: 88-90.
Okamura K, Abe Y, Fukai K, Tsuruta D, Suga Y, Nakamura M, Funasaka Y, Oka M, Suzuki N, Wataya-Kaneda M, Seishima M, Hozumi Y, Kawaguchi M, Suzuki T.
-
3. Immunohistopathological analysis of frizzled-4-positive immature melanocytes from hair follicles of patients with Rhododenol-induced leukoderma. J Dermatol Sci 2015; 80: 156-158.
Okamura K, Ohe R, Abe Y, Ueki M, Hozumi Y, Tamiya G, Matsunaga K, Yamakawa M, Suzuki T.
-
4. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin. J Dermatol Sci 2016; 81: 35-43.
Abe Y, Okamura K, Kawaguchi M, Hozumi Y, Aoki H, Kunisada T, Ito S, Wakamatsu K, Matsunaga K, Suzuki T.
-
5. Genetic analyses of oculocutaneous albinism types 2 and 4 with eight novel mutations. J Dermatol Sci 2016; 81: 140-142.
Okamura K, Araki Y, Abe Y, Shigyou A, Fujiyama T, Baba A, Kanekura T, Chinen Y, Kono M, Niizeki H, Tsubota A, Konno T, Hozumi Y, Suzuki T.
-
6. Behavior of melanocytes and keratinocytes in reticulate acropigmentation of Kitamura. Pigment Cell Melanoma Res 2016; 29: 243-246.
Okamura K, Abe Y, Araki Y, Hozumi Y, Kawaguchi M, Suzuki T.
-
7. Whole-exome sequencing confirmation of multiple MC1R variants associated with extensive freckles and red hair: Analysis of a Mongolian family. J Dermatol Sci 2016; 84: 216-219.
Araki Y, Okamura K, Munkhbat B, Tamiya G, Erdene-Ochir B, Nemekhbaatar L, Hozumi Y, Suzuki T.
-
8. Microsatellite polymorphism located immediately upstream of the phosphatidylinositol glycan, class K gene （PIGK） affects its expression, which correlates with tyrosinase activity in human melanocytes. J Dermatol Sci 2017; 85: 131-134.
Okamura K, Hayashi M, Abe Y, Araki Y, Hozumi Y, Suzuki T.
-
9. Characterization of melanosomes and melanin in Japanese patients with Hermansky-Pudlak syndrome types 1, 4, 6, and 9. Pigment Cell Melanoma Res 2018; 31: 267-276.
Okamura K, Abe Y, Araki Y, Wakamatsu K, Seishima M, Umetsu T, Kato A, Kawaguchi M, Hayashi M, Hozumi Y, Suzuki T.
-
10. Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin. Skin Res Technol 2018; 24: 175-179.
Hayashi M, Okamura K, Araki Y, Suzuki M, Tanaka T, Abe Y, Nakano S, Yoshizawa J, Hozumi Y, Inoie M, Suzuki T.
-
11. A 4-bp deletion promoter variant （rs984225803） is associated with mild OCA4 among Japanese patients. Pigment Cell Melanoma Res 2019; 32: 79-84.
Okamura K, Hayashi M, Nakajima O, Kono M, Abe Y, Hozumi Y, Suzuki T.
-
12. NGS-based targeted resequencing identified rare subtypes of albinism; providing accurate molecular diagnosis for Japanese patients with albinism. Pigment Cell Melanoma Res 2019; 32: 848-853.
Okamura K, Hayashi M, Abe Y, Kono M, Nakajima K, Aoyama Y, Nishigori C, Ishimoto H, Ishimatsu Y, Nakajima M, Hozumi Y, Suzuki T.
-
13. Genome-wide association study identifies CDH13 as a susceptibility gene for rhododendrol-induced leukoderma. Pigment Cell Melanoma Res 2020; 33: 826-833.
-
14. Expression of discoidin domain receptor 1 and E-cadherin in epidermis affects melanocyte behavior in rhododendrol-induced leukoderma mouse model. J Dermatol 2020; 47: 1330-1334.
Abe Y, Hozumi Y, Okamura K, Suzuki T.
-
15. Identification of two novel mutations in a Japanese patient with Hermansky-Pudlak syndrome type 5. J Dermatol 2020; 47: e392-e393.
Saito T, Okamura K, Funasaka Y, Abe Y, Suzuki T.
-
16. Five novel mutations in SASH1 contribute to lentiginous phenotypes in Japanese families. Pigment Cell Melanoma Res 2021; 34: 174-178.
Araki Y, Okamura K, Saito T, Matsumoto K, Natsuga K, Nishimoto J, Funasaka Y, Togawa Y, Suzuki T.
-
17. AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma. J Exp Med 2021; 218: e20200962.
Fukuda K, Okamura K, Riding RL, Fan X, Afshari K, Haddadi NS, McCauley SM, Guney MH, Luban J, Funakoshi T, Yaguchi T, Kawakami Y, Khvorova A, Fitzgerald KA, Harris JE.
-
18. Current landscape of Oculocutaneous Albinism in Japan. Pigment Cell Melanoma Res 2021; 34: 190-203.
Okamura K, Suzuki T.
-
19. Gaining Insight into Vitiligo Genetics through the Lens of a Large Epidemiologic Study. J Invest Dermatol 2021; 141: 718-721.
Okamura K, Garber M, Harris JE.
-
20. Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 6. Pigment Cell Melanoma Res 2021; 35: 212-219.
Saito T, Okamura K, Kosaki R, Wakamatsu K, Ito S, Nakajima O, Yamashita H, Hozumi Y, Suzuki T.
-
21. The effect of a topical vitamin D3 analog on repigmentation in mice with rhododendrol-induced leukoderma. J Dermatol Sci 2022; 106: 127-129.
Abe Y, Okamura K, Ito S, Hozumi Y, Suzuki T.
-
22. Activation of the NLRP1 inflammasome in human keratinocytes by the dsDNA mimetic poly（dA:dT）. Proc Natl Acad Sci U S A 2023; 120: e2213777120.
Zhou JY, Sarkar MK, Okamura K, Harris JE, Gudjonsson JE, Fitzgerald KA.
-
23. Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin. Nat Commun 2023; 14: 7099.
Tang Q, Fakih HH, Zain Ui Abideen M, Hildebrand SR, Afshari K, Gross KY, Sousa J, Maebius AS, Bartholdy C, Sogaard PP, Jackerott M, Hariharan V, Summers A, Fan X, Okamura K, Monopoli KR, Cooper DA, Echeverria D, Bramato B, McHugh N, Furgal RC, Dresser K, Winter SJ, Biscans A, Chuprin J, Haddadi NS, Sherman S, Yildiz-Altay U, Rashighi M, Richmond JM, Bouix-Peter C, Blanchard C, Clauss A, Alterman JF, Khvorova A, Harris JE.
-
24. Resident memory T cell contributes to the phenotype of inflammatory vitiligo. J Dermatol Sci 2024; 113: 74-76.
Okamura K, Kabasawa T, Saito T, Arai Y, Futakuchi M, Suzuki T.
-
25. Genetic insights into Tietz albinism‐deafness syndrome: A new dominant‐negative mutation in MITF. Pigment Cell Melanoma Res 2024; doi: 10.1111/pcmr.13166.
Yamamoto K, Okamura K, Wakamatsu K, Ito S, Akabane K, Arai Y, Kawaguchi J, Hozumi Y, Suzuki T.
